© Copyright Nostre Net
Market Highlights
The tissue transglutaminase (tTG) testing is used for the diagnosis of
certain autoimmune diseases, which is mostly restricted to celiac disease. In
celiac disease, gluten (a protein found in wheat, barley, rye, and oats) is
seen as a foreign invader and in response to it the body mounts an immune
response to its enacting enzyme known as transglutaminase (which restricts the
proteolysis of the glutin). tTG enzyme gets attacked by the (tTG) IgA and
(tTG) IgG. For diagnostic purposes (tTG) IgA is exploited more frequently than
the tTG (IgG) as tTG (IgG).
Increasing prevalence of celiac disease drives the growth of the tissue
transglutaminase test market size. According to the World Gastroenterology
Organization in 2016, 1% of the total population in western countries was
diagnosed with the celiac diseases and the prevalence have substantially
increased across the globe. According to Celiac Disease Foundation in 2016,
hospitalization have increased by 600% from 1998 to 2013.
Get Sample Report @ https://www.marketresearchfuture.com/sample_request/824
Global tTG testing Market
Some of key players profiled in the report are Quest Diagnostics
Incorporated., SQI Diagnostics, Trinity Biotech, ZEDIRA GmbH, Demeditec
Diagnostics GmbH, ARUP Laboratories, Cell Science Systems, Bio-Rad
Laboratories, Inc., Pfizer Inc., Celimmune, LLC., and others.
Segmentation
The global tissue transglutaminase testing market has been
segmented on the basis types and end users.
Based on types, the market has been segmented into
serological, biopsy testing, and others. The serological testing is
sub-segmented into tissue transglutaminase (tTG) antibody- IgA, serum and
tissue transglutaminase (tTG) antibody- IgG, serum.
Based on the end users, the market has been segmented as
hospitals & clinics, homecare, research organizations, and others.
Regional Analysis
The Americas account for a significant market share owing to extensive use
of medications and high expenditure on the health care. Additionally, the
fastest uptake of new technology in the US drives the global tTG testing
market. Additionally, concentration of major research companies and research
organizations in the developed countries of this region boost the market
growth.
Europe is the second largest market in the world due to high
income and healthcare penetration.
Asia Pacific region is expected to grow rapidly. China and
India are likely to lead this market due to fast growing healthcare sector
during the forecast period.
Gulf nations such as Saudi Arabia and the UAE are estimated
to drive the Middle East & African market. The African region is expected
to witness a moderate growth owing to poor economic and political conditions
and poor healthcare development.
Taste the market data and market information presented
through more than 50 market data tables and figures spread over 80 pages of the
project report. Avail the in-depth table of content (TOC) & market synopsis
on “global tissue transglutaminase testing market” research report – Forecast
till 2023.
Access full report @ https://www.marketresearchfuture.com/reports/tissue-transglutaminase-test-market-824
About US:
Market Research Future (MRFR), enable
customers to unravel the complexity of various industries through Cooked
Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research
Reports (3R), Continuous-Feed Research (CFR), and Market Research &
Consulting Services.
Contact us:
Market Research Future (part of
Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America
The Wall